Cargando…

Use of Middleware Data to Dissect and Optimize Hematology Autoverification

BACKGROUND: Hematology analysis comprises some of the highest volume tests run in clinical laboratories. Autoverification of hematology results using computer-based rules reduces turnaround time for many specimens, while strategically targeting specimen review by technologist or pathologist. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Starks, Rachel D., Merrill, Anna E., Davis, Scott R., Voss, Dena R., Goldsmith, Pamela J., Brown, Bonnie S., Kulhavy, Jeff, Krasowski, Matthew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240550/
https://www.ncbi.nlm.nih.gov/pubmed/34221635
http://dx.doi.org/10.4103/jpi.jpi_89_20
_version_ 1783715234667560960
author Starks, Rachel D.
Merrill, Anna E.
Davis, Scott R.
Voss, Dena R.
Goldsmith, Pamela J.
Brown, Bonnie S.
Kulhavy, Jeff
Krasowski, Matthew D.
author_facet Starks, Rachel D.
Merrill, Anna E.
Davis, Scott R.
Voss, Dena R.
Goldsmith, Pamela J.
Brown, Bonnie S.
Kulhavy, Jeff
Krasowski, Matthew D.
author_sort Starks, Rachel D.
collection PubMed
description BACKGROUND: Hematology analysis comprises some of the highest volume tests run in clinical laboratories. Autoverification of hematology results using computer-based rules reduces turnaround time for many specimens, while strategically targeting specimen review by technologist or pathologist. METHODS: Autoverification rules had been developed over a decade at an 800-bed tertiary/quarternary care academic medical central laboratory serving both adult and pediatric populations. In the process of migrating to newer hematology instruments, we analyzed the rates of the autoverification rules/flags most commonly associated with triggering manual review. We were particularly interested in rules that on their own often led to manual review in the absence of other flags. Prior to the study, autoverification rates were 87.8% (out of 16,073 orders) for complete blood count (CBC) if ordered as a panel and 85.8% (out of 1,940 orders) for CBC components ordered individually (not as the panel). RESULTS: Detailed analysis of rules/flags that frequently triggered indicated that the immature granulocyte (IG) flag (an instrument parameter) and rules that reflexed platelet by impedance method (PLT-I) to platelet by fluorescent method (PLT-F) represented the two biggest opportunities to increase autoverification. The IG flag threshold had previously been validated at 2%, a setting that resulted in this flag alone preventing autoverification in 6.0% of all samples. The IG flag threshold was raised to 5% after detailed chart review; this was also the instrument vendor's default recommendation for the newer hematology analyzers. Analysis also supported switching to PLT-F for all platelet analysis. Autoverification rates increased to 93.5% (out of 91,692 orders) for CBC as a panel and 89.8% (out of 11,982 orders) for individual components after changes in rules and laboratory practice. CONCLUSIONS: Detailed analysis of autoverification of hematology testing at an academic medical center clinical laboratory that had been using a set of autoverification rules for over a decade revealed opportunities to optimize the parameters. The data analysis was challenging and time-consuming, highlighting opportunities for improvement in software tools that allow for more rapid and routine evaluation of autoverification parameters.
format Online
Article
Text
id pubmed-8240550
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-82405502021-07-02 Use of Middleware Data to Dissect and Optimize Hematology Autoverification Starks, Rachel D. Merrill, Anna E. Davis, Scott R. Voss, Dena R. Goldsmith, Pamela J. Brown, Bonnie S. Kulhavy, Jeff Krasowski, Matthew D. J Pathol Inform Technical Note BACKGROUND: Hematology analysis comprises some of the highest volume tests run in clinical laboratories. Autoverification of hematology results using computer-based rules reduces turnaround time for many specimens, while strategically targeting specimen review by technologist or pathologist. METHODS: Autoverification rules had been developed over a decade at an 800-bed tertiary/quarternary care academic medical central laboratory serving both adult and pediatric populations. In the process of migrating to newer hematology instruments, we analyzed the rates of the autoverification rules/flags most commonly associated with triggering manual review. We were particularly interested in rules that on their own often led to manual review in the absence of other flags. Prior to the study, autoverification rates were 87.8% (out of 16,073 orders) for complete blood count (CBC) if ordered as a panel and 85.8% (out of 1,940 orders) for CBC components ordered individually (not as the panel). RESULTS: Detailed analysis of rules/flags that frequently triggered indicated that the immature granulocyte (IG) flag (an instrument parameter) and rules that reflexed platelet by impedance method (PLT-I) to platelet by fluorescent method (PLT-F) represented the two biggest opportunities to increase autoverification. The IG flag threshold had previously been validated at 2%, a setting that resulted in this flag alone preventing autoverification in 6.0% of all samples. The IG flag threshold was raised to 5% after detailed chart review; this was also the instrument vendor's default recommendation for the newer hematology analyzers. Analysis also supported switching to PLT-F for all platelet analysis. Autoverification rates increased to 93.5% (out of 91,692 orders) for CBC as a panel and 89.8% (out of 11,982 orders) for individual components after changes in rules and laboratory practice. CONCLUSIONS: Detailed analysis of autoverification of hematology testing at an academic medical center clinical laboratory that had been using a set of autoverification rules for over a decade revealed opportunities to optimize the parameters. The data analysis was challenging and time-consuming, highlighting opportunities for improvement in software tools that allow for more rapid and routine evaluation of autoverification parameters. Wolters Kluwer - Medknow 2021-04-07 /pmc/articles/PMC8240550/ /pubmed/34221635 http://dx.doi.org/10.4103/jpi.jpi_89_20 Text en Copyright: © 2021 Journal of Pathology Informatics https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Technical Note
Starks, Rachel D.
Merrill, Anna E.
Davis, Scott R.
Voss, Dena R.
Goldsmith, Pamela J.
Brown, Bonnie S.
Kulhavy, Jeff
Krasowski, Matthew D.
Use of Middleware Data to Dissect and Optimize Hematology Autoverification
title Use of Middleware Data to Dissect and Optimize Hematology Autoverification
title_full Use of Middleware Data to Dissect and Optimize Hematology Autoverification
title_fullStr Use of Middleware Data to Dissect and Optimize Hematology Autoverification
title_full_unstemmed Use of Middleware Data to Dissect and Optimize Hematology Autoverification
title_short Use of Middleware Data to Dissect and Optimize Hematology Autoverification
title_sort use of middleware data to dissect and optimize hematology autoverification
topic Technical Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240550/
https://www.ncbi.nlm.nih.gov/pubmed/34221635
http://dx.doi.org/10.4103/jpi.jpi_89_20
work_keys_str_mv AT starksracheld useofmiddlewaredatatodissectandoptimizehematologyautoverification
AT merrillannae useofmiddlewaredatatodissectandoptimizehematologyautoverification
AT davisscottr useofmiddlewaredatatodissectandoptimizehematologyautoverification
AT vossdenar useofmiddlewaredatatodissectandoptimizehematologyautoverification
AT goldsmithpamelaj useofmiddlewaredatatodissectandoptimizehematologyautoverification
AT brownbonnies useofmiddlewaredatatodissectandoptimizehematologyautoverification
AT kulhavyjeff useofmiddlewaredatatodissectandoptimizehematologyautoverification
AT krasowskimatthewd useofmiddlewaredatatodissectandoptimizehematologyautoverification